S&P 500   4,274.51 (+0.02%)
DOW   33,550.27 (-0.20%)
QQQ   355.04 (+0.23%)
AAPL   170.43 (-0.89%)
MSFT   312.79 (+0.21%)
META   297.74 (-0.41%)
GOOGL   130.54 (+1.53%)
AMZN   125.98 (+0.00%)
TSLA   240.50 (-1.48%)
NVDA   424.68 (+1.33%)
NIO   8.47 (+0.71%)
BABA   86.19 (+0.33%)
AMD   98.07 (+2.20%)
T   14.88 (-0.93%)
F   12.39 (-0.32%)
MU   68.21 (+0.40%)
CGC   0.89 (-3.49%)
GE   110.85 (+0.84%)
DIS   79.89 (-0.20%)
AMC   7.57 (-4.30%)
PFE   32.11 (-0.93%)
PYPL   57.34 (-2.70%)
NFLX   377.59 (-0.44%)
S&P 500   4,274.51 (+0.02%)
DOW   33,550.27 (-0.20%)
QQQ   355.04 (+0.23%)
AAPL   170.43 (-0.89%)
MSFT   312.79 (+0.21%)
META   297.74 (-0.41%)
GOOGL   130.54 (+1.53%)
AMZN   125.98 (+0.00%)
TSLA   240.50 (-1.48%)
NVDA   424.68 (+1.33%)
NIO   8.47 (+0.71%)
BABA   86.19 (+0.33%)
AMD   98.07 (+2.20%)
T   14.88 (-0.93%)
F   12.39 (-0.32%)
MU   68.21 (+0.40%)
CGC   0.89 (-3.49%)
GE   110.85 (+0.84%)
DIS   79.89 (-0.20%)
AMC   7.57 (-4.30%)
PFE   32.11 (-0.93%)
PYPL   57.34 (-2.70%)
NFLX   377.59 (-0.44%)
S&P 500   4,274.51 (+0.02%)
DOW   33,550.27 (-0.20%)
QQQ   355.04 (+0.23%)
AAPL   170.43 (-0.89%)
MSFT   312.79 (+0.21%)
META   297.74 (-0.41%)
GOOGL   130.54 (+1.53%)
AMZN   125.98 (+0.00%)
TSLA   240.50 (-1.48%)
NVDA   424.68 (+1.33%)
NIO   8.47 (+0.71%)
BABA   86.19 (+0.33%)
AMD   98.07 (+2.20%)
T   14.88 (-0.93%)
F   12.39 (-0.32%)
MU   68.21 (+0.40%)
CGC   0.89 (-3.49%)
GE   110.85 (+0.84%)
DIS   79.89 (-0.20%)
AMC   7.57 (-4.30%)
PFE   32.11 (-0.93%)
PYPL   57.34 (-2.70%)
NFLX   377.59 (-0.44%)
S&P 500   4,274.51 (+0.02%)
DOW   33,550.27 (-0.20%)
QQQ   355.04 (+0.23%)
AAPL   170.43 (-0.89%)
MSFT   312.79 (+0.21%)
META   297.74 (-0.41%)
GOOGL   130.54 (+1.53%)
AMZN   125.98 (+0.00%)
TSLA   240.50 (-1.48%)
NVDA   424.68 (+1.33%)
NIO   8.47 (+0.71%)
BABA   86.19 (+0.33%)
AMD   98.07 (+2.20%)
T   14.88 (-0.93%)
F   12.39 (-0.32%)
MU   68.21 (+0.40%)
CGC   0.89 (-3.49%)
GE   110.85 (+0.84%)
DIS   79.89 (-0.20%)
AMC   7.57 (-4.30%)
PFE   32.11 (-0.93%)
PYPL   57.34 (-2.70%)
NFLX   377.59 (-0.44%)

Medical Properties Trust (MPW) Stock Forecast, Price & News

$5.03
-0.01 (-0.20%)
(As of 09/27/2023 ET)
Compare
Today's Range
$4.97
$5.15
50-Day Range
$5.05
$10.63
52-Week Range
$4.97
$14.00
Volume
15.56 million shs
Average Volume
14.09 million shs
Market Capitalization
$3.01 billion
P/E Ratio
45.73
Dividend Yield
11.93%
Price Target
$10.55

Medical Properties Trust MarketRank™ Forecast

Analyst Rating
Hold
2.00 Rating Score
Upside/​Downside
109.7% Upside
$10.55 Price Target
Short Interest
Bearish
22.56% of Shares Sold Short
Dividend Strength
Moderate
Based on Four Factors
Sustainability
-1.18
Upright™ Environmental Score
News Sentiment
1.05mentions of Medical Properties Trust in the last 14 days
Based on 11 Articles This Week
Insider Trading
N/A
Proj. Earnings Growth
-1.95%
From $1.54 to $1.51 Per Share

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

2.72 out of 5 stars

Finance Sector

235th out of 870 stocks

Real Estate Investment Trusts Industry

45th out of 180 stocks


MPW stock logo

About Medical Properties Trust (NYSE:MPW) Stock

Medical Properties Trust Inc. is a real estate investment trust (REIT) specializing in acquiring and developing healthcare facilities. The company's portfolio comprises properties across the United States and Europe, including acute care hospitals, long-term acute care hospitals, rehabilitation hospitals, and other healthcare facilities.

Since 2003, Medical Properties Trust Inc. has become a leading player in the healthcare real estate industry. The company's strategy is centered on long-term leases with high-quality tenants, providing stable cash flow and reducing the risk associated with occupancy and rental rate volatility. Medical Properties Trust Inc. has a strong track record of growth and profitability. 

One of the critical drivers of Medical Properties Trust Inc.'s success is its focus on the healthcare industry. With an aging population and increasing demand for healthcare services, the healthcare industry is expected to continue growing in the coming years. As a result, the need for healthcare facilities is likely to increase, which should benefit Medical Properties Trust Inc.  

Additionally, the company's focus on long-term leases with high-quality tenants provides stability and predictability, which is especially important in the healthcare industry, where occupancy and rental rate volatility can be high.

Medical Properties Trust Inc. has an excellent management team with a proven track record of success. Under the company's current leadership, Medical Properties Trust Inc. has grown rapidly and consistently outperformed its peers. The company's management team has also demonstrated a commitment to sustainability and social responsibility. In 2020, Medical Properties Trust Inc. was recognized as a leader in sustainability performance.

Medical Properties Trust Inc. is exposed to general economic conditions, regulatory changes, and competition within the healthcare real estate industry. The company's success is also dependent on the performance of its tenants, which may be affected by factors such as changes in healthcare laws, reimbursement rates, and patient volumes. Additionally, the company's focus on healthcare real estate may limit its ability to diversify its portfolio in the event of a downturn in the healthcare industry.

Despite the risks, Medical Properties Trust Inc. has shown resilience during the COVID-19 pandemic. The pandemic has highlighted the critical importance of healthcare facilities, and the company's portfolio of high-quality properties has continued to generate strong cash flows. Medical Properties Trust Inc. has used the pandemic to acquire additional properties at attractive valuations.

Medical Properties Trust Inc. is well-positioned to benefit from several long-term trends in the healthcare industry:

  1. The aging population is expected to increase the demand for healthcare services, including acute care hospitals, rehabilitation hospitals, and long-term care facilities.
  2. The shift towards value-based care drives consolidation in the healthcare industry, likely resulting in increased demand for healthcare facilities.
  3. Advances in medical technology are increasing the need for specialized facilities, such as proton therapy and cancer treatment centers.

Medical Properties Trust Inc.'s financial position is strong, with a healthy balance sheet and access to capital markets. The company has consistently maintained an investment-grade credit rating and low capital cost, allowing it to finance growth. Additionally, the company has a diversified tenant base, with no single tenant accounting for more than 4% of its annualized base rent. This provides stability and reduces the risk associated with tenant concentration.

MPW Price History

MPW Stock News Headlines

The World's First "$20 Trillion Drug
?" One small biotech holds the key to a revolution in treating Alzheimer's disease. Jeff Bezos, Goldman Sachs & Big Pharma giants have invested billions into this unknown biotech. Our research proves that anyone who gets in today could see 113,000% gains! Get the name of the stock here >>>
RBC Capital Reaffirms Their Buy Rating on Medical Properties (MPW)
The World's First "$20 Trillion Drug
?" One small biotech holds the key to a revolution in treating Alzheimer's disease. Jeff Bezos, Goldman Sachs & Big Pharma giants have invested billions into this unknown biotech. Our research proves that anyone who gets in today could see 113,000% gains! Get the name of the stock here >>>
Down 35%, Is Medical Properties Trust a Buy?
Medical Properties Trust: Dividend Insights
See More Headlines
Receive MPW Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Medical Properties Trust and its competitors with MarketBeat's FREE daily newsletter.

MPW Company Calendar

Last Earnings
4/28/2022
Ex-Dividend for 7/13 Dividend
6/14/2023
Dividend Payable
7/13/2023
Ex-Dividend for 10/12 Dividend
9/13/2023
Today
9/27/2023
Dividend Payable
10/12/2023
Next Earnings (Estimated)
10/26/2023
Fiscal Year End
12/31/2023

Industry, Sector and Symbol

Industry
Real estate investment trusts
Sub-Industry
Specialized REITs
Sector
Finance
CUSIP
58463J30
Employees
119
Year Founded
N/A

Price Target and Rating

Average Stock Price Forecast
$10.55
High Stock Price Forecast
$16.00
Low Stock Price Forecast
$7.00
Forecasted Upside/Downside
+108.8%
Consensus Rating
Hold
Rating Score (0-4)
2.00
Research Coverage
10 Analysts

Profitability

Net Income
$902.60 million
Pretax Margin
-2.71%

Debt

Sales & Book Value

Annual Sales
$1.54 billion
Cash Flow
$2.02 per share
Book Value
$14.37 per share

Miscellaneous

Free Float
591,100,000
Market Cap
$3.02 billion
Optionable
Optionable
Beta
1.03

Social Links

5G Stocks: The Path Forward is Profitable Cover

Click the link below and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise.

Get This Free Report

Key Executives

  • Mr. Edward K. Aldag Jr.Mr. Edward K. Aldag Jr. (Age 59)
    Founder, Chairman, Pres & CEO
    Comp: $3.65M
  • Mr. Emmett E. McLeanMr. Emmett E. McLean (Age 68)
    Founder, Exec. VP, COO & Sec.
    Comp: $1.35M
  • Mr. R. Steven Hamner CPAMr. R. Steven Hamner CPA (Age 66)
    Founder, Exec. VP, CFO & Director
    Comp: $1.97M
  • Mr. James Kevin HannaMr. James Kevin Hanna (Age 50)
    Sr. VP, Chief Accounting Officer & Controller
  • Mr. Tim Berryman
    Managing Director of Investor Relations
  • Mr. Andrew T. Babin C.F.A.
    Sr. Managing Director of Corp. Communications
  • Ms. Rosa H. Hooper
    Sr. VP of Operations, Assistant Sec. and MD of Asset Management & Underwriting
  • Mr. R. Lucas Savage
    VP & Head of Global Acquisitions
  • Mr. Larry H. Portal
    Sr. VP & Sr. Advisor to the CEO
  • Mr. Charles R. Lambert (Age 52)
    VP, Treasurer & MD of Capital Markets













MPW Stock - Frequently Asked Questions

Should I buy or sell Medical Properties Trust stock right now?

10 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Medical Properties Trust in the last twelve months. There are currently 3 sell ratings, 4 hold ratings and 3 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "hold" MPW shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in MPW, but not buy additional shares or sell existing shares.
View MPW analyst ratings
or view top-rated stocks.

What is Medical Properties Trust's stock price forecast for 2023?

10 brokers have issued 1-year target prices for Medical Properties Trust's shares. Their MPW share price forecasts range from $7.00 to $16.00. On average, they anticipate the company's stock price to reach $10.55 in the next year. This suggests a possible upside of 108.8% from the stock's current price.
View analysts price targets for MPW
or view top-rated stocks among Wall Street analysts.

How have MPW shares performed in 2023?

Medical Properties Trust's stock was trading at $11.14 on January 1st, 2023. Since then, MPW stock has decreased by 54.7% and is now trading at $5.05.
View the best growth stocks for 2023 here
.

When is Medical Properties Trust's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Thursday, October 26th 2023.
View our MPW earnings forecast
.

How were Medical Properties Trust's earnings last quarter?

Medical Properties Trust, Inc. (NYSE:MPW) announced its earnings results on Thursday, April, 28th. The real estate investment trust reported $1.05 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.47 by $0.58. The real estate investment trust earned $409.80 million during the quarter, compared to analyst estimates of $413.31 million. Medical Properties Trust had a trailing twelve-month return on equity of 0.84% and a net margin of 5.07%. The firm's quarterly revenue was up 13.0% on a year-over-year basis. During the same quarter in the previous year, the firm posted $0.42 earnings per share.

How often does Medical Properties Trust pay dividends? What is the dividend yield for Medical Properties Trust?

Medical Properties Trust declared a quarterly dividend on Monday, August 21st. Shareholders of record on Thursday, September 14th will be given a dividend of $0.15 per share on Thursday, October 12th. This represents a $0.60 dividend on an annualized basis and a dividend yield of 11.88%. The ex-dividend date is Wednesday, September 13th.
Read our dividend analysis for MPW
.

Is Medical Properties Trust a good dividend stock?

Medical Properties Trust (NYSE:MPW) pays an annual dividend of $0.60 per share and currently has a dividend yield of 11.36%. MPW has a dividend yield higher than 75% of all dividend-paying stocks, making it a leading dividend payer. The dividend payout ratio is 545.45%. Payout ratios above 75% are not desirable because they may not be sustainable. Based on earnings estimates, MPW will have a dividend payout ratio of 39.74% next year. This indicates that the company will be able to sustain or increase its dividend.
Read our dividend analysis for MPW.

What guidance has Medical Properties Trust issued on next quarter's earnings?

Medical Properties Trust issued an update on its FY 2023 earnings guidance on Tuesday, August, 8th. The company provided earnings per share guidance of $1.53-$1.57 for the period, compared to the consensus EPS estimate of $1.55. The company issued revenue guidance of -.

What other stocks do shareholders of Medical Properties Trust own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Medical Properties Trust investors own include AT&T (T), Verizon Communications (VZ), Energy Transfer (ET), Enterprise Products Partners (EPD), Omega Healthcare Investors (OHI), New Residential Investment (NRZ), Cisco Systems (CSCO), Pfizer (PFE), AbbVie (ABBV) and Intel (INTC).

What is Medical Properties Trust's stock symbol?

Medical Properties Trust trades on the New York Stock Exchange (NYSE) under the ticker symbol "MPW."

Who are Medical Properties Trust's major shareholders?

Medical Properties Trust's stock is owned by a number of institutional and retail investors. Top institutional investors include BlackRock Inc. (11.57%), Cohen & Steers Inc. (7.71%), State Street Corp (5.60%), Geode Capital Management LLC (1.95%), Centersquare Investment Management LLC (1.85%) and Daiwa Securities Group Inc. (1.63%). Insiders that own company stock include Edward K Aldag Jr, James Kevin Hanna, Michael G Stewart and R Steven Hamner.
View institutional ownership trends
.

How do I buy shares of Medical Properties Trust?

Shares of MPW stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Medical Properties Trust's stock price today?

One share of MPW stock can currently be purchased for approximately $5.05.

How much money does Medical Properties Trust make?

Medical Properties Trust (NYSE:MPW) has a market capitalization of $3.02 billion and generates $1.54 billion in revenue each year. The real estate investment trust earns $902.60 million in net income (profit) each year or $0.11 on an earnings per share basis.

How many employees does Medical Properties Trust have?

The company employs 119 workers across the globe.

How can I contact Medical Properties Trust?

Medical Properties Trust's mailing address is 1000 URBAN CENTER DRIVE SUITE 501, BIRMINGHAM AL, 35242. The official website for the company is www.medicalpropertiestrust.com. The real estate investment trust can be reached via phone at (205) 969-3755, via email at tberryman@medicalpropertiestrust.com, or via fax at 205-969-3756.

This page (NYSE:MPW) was last updated on 9/27/2023 by MarketBeat.com Staff

My Account -